[1]
Kania, B. et al. 2022. Unintentional Dual Benefit: Improvement in Secondary Polycythemia in a Patient Receiving Chemotherapy for Metastatic Clear Cell Renal Cell Carcinoma. European Journal of Case Reports in Internal Medicine. 9, 2 (Feb. 2022). DOI:https://doi.org/10.12890/2022_003125.